K2M Acquires Expandable Interbody IP Portfolio

K2M acquired exclusive license to a portfolio of 17 issued and pending patents for expandable interbody fusion devices (IBFs), which will support development of new products using Lamellar 3D Titanium Technology™.

K2M expects the IP will yield devices with greater expansion capabilities than many available today.

The company is already...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.

Contact Us